Clinical Trial

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

Study acronym: PRP-I RCT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates whether adding topical insulin to intranasal platelet-rich plasma (PRP) improves smell recovery in adults with post-inflammatory anosmia. Participants will be randomly assigned to receive either intranasal PRP combined with topical insulin or intranasal PRP alone. Changes in olfactory function will be assessed over time to compare the effectiveness and safety of the two treatments.
Trial Details
NCT Number NCT07383415
Lead Sponsor Amin Javer
Conditions Anosmia, Inflammatory Anosmia
Enrollment 20 participants
Start Date 2026-03-30
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-03